Glioblastoma Multiforme (GBM) is one of the most aggressive and treatment-resistant brain cancers, posing significant challenges due to its rapid growth, high recurrence rate, and limited response to conventional therapies. However, ongoing advancements in the Glioblastoma Multiforme market are bringing new hope through innovative treatment strategies and novel drug developments. This article...